All News Pharmaron Beijing Co., Ltd.

Equities

300759

CNE100003JW4

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-22 pm EDT			5-day change	1st Jan Change
18.46 ^CNY	+1.60%		-2.94%	-36.30%

Apr. 08	Pharmaron Partners Seven Firms to Float 2 Billion Yuan Fund	MT
Mar. 28	Pharmaron's 2023 Profit, Revenue Rise; Misses Estimates	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pharmaron Partners Seven Firms to Float 2 Billion Yuan Fund	Apr. 08	MT
Pharmaron's 2023 Profit, Revenue Rise; Misses Estimates	Mar. 28	MT
Pharmaron Beijing Co., Ltd. Proposes Final Dividend for the Financial Year Ended December 31, 2023	Mar. 27	CI
Pharmaron Beijing Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
Nomura Adjusts Pharmaron Beijing’s Price Target to HK$17.99 From HK$30.92, Keeps at Buy	Mar. 06	MT
Pharmaron Beijing Sees Up to 14% Jump in 2023 Profit	Jan. 29	MT
Pharmaron Forecasts Up to 19% Rise in 2023 Attributable Profit	Jan. 29	MT
Pharmaron Beijing Co., Ltd. Provides Earnings Guidance for the Financial Year Ended December 31, 2023	Jan. 28	CI
Pharmaron Beijing Buys Back Additional Series 2 Bonds	Jan. 15	MT
Pharmaron Beijing Buys Back $68 Million of Convertible Bonds Due 2026	Jan. 12	MT
Pharmaron Beijing Buys Back 705 Million Yuan of Series 2 Bonds Due 2026	Jan. 12	MT
Pharmaron's Q3 Attributable Profit Rises 6%; Shenzhen Shares Surge 12%	23-10-30	MT
Pharmaron Beijing Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-29	CI
Nomura Adjusts Pharmaron’s Price Target to 61.24 Yuan From 66.94 Yuan, Keeps at Buy	23-10-25	MT
CORRECTION, Skye Bioscience to Host Virtual Investor Day on October 25, 2023, 'CB1 Axis: Unlocking the Pharmaceutical Potential of the Endocannabinoid System'	23-10-23	AQ
Pharmaron's Profit Climbs 34.3% in H1	23-08-28	MT
Pharmaron Beijing Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-27	CI
Pharmaron Beijing's Profit to Jump Up to 36% in H1; Shares Jump 10%	23-07-31	MT
Pharmaron Slashes Conversion Price of Zero-Coupon Convertible Bonds Due 2026	23-07-26	MT
Nomura Adjusts Pharmaron’s Price Target to 66.94 Yuan From 73.38 Yuan, Keeps at Buy	23-07-24	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Pharmaron Beijing Co., Ltd.

Equities

300759

CNE100003JW4

All News

Filters